Vasomune Therapeutics
PrivateLast Round
Strategic
Nov 25, 2025
Total Funding Raised
$14.75M
Company Overview
Vasomune Therapeutics is a biotechnology company that develops novel therapeutics for diseases associated with vascular dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vasomune Therapeutics Comparables
Compare Vasomune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AnGes, Inc. | 83% | |
| Adrenomed AG | 78% | |
| Aqualung Therapeutics Corporation | 77% | |
Vasomune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 25, 2025 | ||||
| Series A | Jan 1, 2023 | ||||
| Grant | Nov 8, 2021 | ||||
| Grant | Nov 8, 2021 | ||||
| Grant | Aug 18, 2020 | ||||
Seed | Oct 20, 2014 |
Key People
Founding team and executive leadership
Vasomune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of War | Grant |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Genome Canada | Seed |
| TIAP | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2024
Grew 50% QoQ from 6 to 9 employees.
- Nov 8, 2021
$2.21M grant received from NRC IRAP.
Vasomune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vasomune Therapeutics's valuation, stock price, and market status.